Global Biopreservation Media Market by Type (Home-brew Media, Pre-formulated Media), by Application (Biobanking, Regenerative Medicine, Drug Discovery), by Geography (North America, Europe, Asia-Pacific, Rest of the World) - Analysis & Forecast to 2019
The report analyses the global biopreservation media market by type, application, and geography. The regions covered in the report include North America, Europe, Asia-Pacific and Rest of the World (RoW). This market is estimated to grow at a CAGR of 18.2% during the forecast period of 2014 to 2019.
North America is the largest biopreservation media market with a market share of 47.3%, and is expected to grow at a CAGR of 17.7% during the forecast period. North America is followed by Europe. Asia-Pacific is the fastest-growing market with an estimated CAGR of 21.2% during the forecast period. Advancements in biotechnology in the U.S. and Canada are driving the market in North America. Companies that offer biopreservation media in North America are majorly focusing on the strategy of expansion.
Regenerative medicines, biobanking, and drug discovery are the major application areas for biopreservation media for preserving cells, tissues, and organs. Due to rapid advancements in these application areas, the demand for biopreservation media is likely to grow extensively in coming years. Huge investments are being made in cell-therapy and regenerative medicine research by the corporates, governments, and non-government organizations, which will have a positive impact on the biopreservation media market in coming years. Cryopreservation, vitrification, and hypothermic storage are the common biopreservation procedures used widely in laboratory and clinical settings presently.
In-depth market share analysis, by revenue, of the top companies is also included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, annual reports and interviews with industry experts and key opinion leaders such as CEOs, directors, and marketing executives. In addition, the report also profiles the key market players on various parameters, such as business overview, financial overview, product portfolio, business strategies, and recent developments of the respective company. Some of the key market players of the global biopreservation market include Lifeline Scientific Inc. (U.S.), BioLife Solutions Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Wak-Chemie Medical GmbH (Germany), VWR International LLC (U.S.), and others.
Table Of Contents
1 Introduction (Page No. - 11)
1.1 Objectives Of The Study
1.2 Market Segmentation & Coverage
1.3 Stakeholders
2 Research Methodology (Page No. - 13)
2.1 Integrated Ecosystem Of The Biopreservation Media Market
2.2 Arriving At The Biopreservation Media Market Size
2.2.1 Top-Down Approach
2.2.2 Macro Indicator Approach
2.3 Assumptions
3 Executive Summary (Page No. - 18)
4 Market Overview (Page No. - 20)
4.1 Introduction
4.2 Market Drivers And Inhibitors
5 Biopreservation Media Market, By Type (Page No. - 28)
5.1 Introduction
5.2 Global Home-Brew Media Market, By Application
5.3 Global Pre-Formulated Media Market, By Application
6 Biopreservation Media Market, By Application (Page No. - 32)
6.1 Introduction
6.2 North America Biopreservation Media Market, By Application
6.3 Europe Biopreservation Media Market, By Application
6.4 Apac Biopreservation Media Market, By Application
7 Biopreservation Media Market, By Geography (Page No. - 38)
7.1 Introduction
7.2 North America Biopreservation Media Market
7.2.1 North America Biopreservation Media Market, By Application
7.3 Europe Biopreservation Media Market
7.3.1 Europe Biopreservation Media Market, By Application
7.4 Apac Biopreservation Media Market
7.4.1 Apac Biopreservation Media Market, By Application
7.5 Row Biopreservation Media Market
7.5.1 Row Biopreservation Media Market, By Application
8 Biopreservation Media Market: Competitive Landscape (Page No. - 49)
8.1 Biopreservation Media Market: Company Share Analysis
8.1.1 Mergers & Acquisitions
8.2 Expansions
8.3 Joint Ventures
9 Company Profile (Page No. - 56)
9.1 Thermo Fisher Scientific Inc.
9.1.1 Overview
9.1.2 Key Financials
9.1.3 Product And Service Offerings
9.1.4 Recent Developments
9.1.5 Mmm View
9.2 Vwr International Llc
9.2.1 Overview
9.2.2 Key Financials
9.2.3 Products And Service Offerings
9.2.4 Recent Developments
9.2.5 Mmm View
9.3 Atlanta Biologicals Inc.
9.3.1 Overview
9.3.2 Key Financials
9.3.3 Products And Service Offerings
9.3.4 Recent Developments
9.3.5 Mmm View
9.4 Biolife Solutions Inc.
9.4.1 Overview
9.4.2 Key Financials
9.4.3 Products And Service Offerings
9.4.4 Recent Developments
9.4.5 Mmm View
9.5 Essential Pharmaceuticals Llc
9.5.1 Overview
9.5.2 Key Financials
9.5.3 Products And Service Offerings
9.5.4 Recent Developments
9.5.5 Mmm View
9.6 Mylan N.V.
9.6.1 Overview
9.6.2 Key Financials
9.6.3 Products And Service Offerings
9.6.4 Recent Developments
9.6.5 Mmm View
9.7 Lifeline Scientific Inc.
9.7.1 Overview
9.7.2 Key Financials
9.7.3 Products And Service Offerings
9.7.4 Recent Developments
9.7.5 Mmm View
9.8 Sigma-Aldrich Corporation
9.8.1 Overview
9.8.2 Key Financials
9.8.3 Products And Service Offerings
9.8.4 Recent Developments
9.8.5 Mmm View
9.9 Wak-Chemie Medical Gmbh
9.9.1 Overview
9.9.2 Key Financials
9.9.3 Products And Service Offerings
9.9.4 Recent Developments
9.9.5 Mmm View
9.1 Lonza Group Ltd
9.10.1 Overview
9.10.2 Key Financials
9.10.3 Products And Service Offerings
9.10.4 Recent Developments
9.10.5 Mmm View
9.11 Akron Biotech
9.11.1 Overview
9.11.2 Key Financials
9.11.3 Product And Service Offerings
9.11.4 Recent Developments
9.11.5 Mmm View
9.12 Origen Biomedicals Inc.
9.12.1 Overview
9.12.2 Key Financials
9.12.3 Products And Service Offerings
9.12.4 Recent Developments
9.12.5 Mmm View
9.13 Genzyme Corporation
9.13.1 Overview
9.13.2 Key Financials
9.13.3 Products And Service Offerings
9.13.4 Recent Developments
9.13.5 Mmm View
9.14 Teva Pharmaceuticals Industries Ltd.
9.14.1 Overview
9.14.2 Key Financials
9.14.3 Products And Service Offerings
9.14.4 Recent Developments
9.14.5 Mmm View
10 Appendix (Page No. - 83)
10.1 Customization Options
10.1.1 Impact Analysis
10.1.2 Product Analysis
10.1.3 Competitive Intelligence
10.2 Introducing Rt: Real Time Market Intelligence
10.3 Rt Snapshot
List Of Tables
Table 1 Global Biopreservation Media Peer Market Size, 2014 (Usd Bn)
Table 2 Global Biopreservation Media Market, By Geography, 2013-2019 (Usd Mn)
Table 3 North America Biopreservation Media Market, By Application,2013-2019 (Usd Mn) 22
Table 4 Europe Biopreservation Media Market, By Application, 2013-2019 (Usd Mn)
Table 5 Apac Biopreservation Media Market, By Application, 2013-2019 (Usd Mn)
Table 6 Row Biopreservation Media Market, By Application, 2013-2019 (Usd Mn)
Table 7 Global Biopreservation Media Market: Drivers And Inhibitors
Table 8 Global Biopreservation Media Market, By Type, 2013-2019 (Usd Mn)
Table 9 Global Home-Brew Media Market, By Application, 2013–2019 (Usd Mn)
Table 10 Global Pre-Formulated Media Market, By Application, 2013–2019 (Usd Mn)
Table 11 Global Biopreservation Media Market, By Application, 2013-2019 (Usd Mn)
Table 12 North America Biopreservation Media Market, By Application,2013-2019(Usd Mn) 34
Table 13 Europe Biopreservation Media Market, By Application, 2013-2019(Usd Mn)
Table 14 Apac Biopreservation Media Market, By Application, 2013-2019(Usd Mn)
Table 15 Global Biopreservation Media Market, By Geography, 2013-2019 (Usd Mn)
Table 16 North America Biopreservation Media Market, By Application, 2013-2019 (Usd Mn)
Table 17 Europe Biopreservation Media Market, By Application, 2013-2019 (Usd Mn)
Table 18 Apac Biopreservation Media Market, By Application, 2013-2019 (Usd Mn)
Table 19 Row Biopreservation Media Market, By Application, 2013-2019 (Usd Mn)
Table 20 Biopreservation Media Market: Company Share Analysis In Bio Banking, 2014 (%)
Table 21 Biopreservation Media Market: Company Share Analysis In Regenerative Medicine 2014 (%)
Table 22 Biopreservation Media Market: Company Share Analysis In Drug Discovery, 2014 (%)
Table 23 Global Biopreservation Media Market: Mergers & Acquisitions
Table 24 Global Biopreservation Media Market: Expansions
Table 25 Global Biopreservation Media Market: Joint Ventures
Table 26 Thermo Fisher Scientific Inc.: Key Financials, 2013-2014 (Usd Mn)
Table 27 Vwr Internationals Llc: Key Financials ,2012-2014 (Usd Mn)
Table 28 Biolife Solutions: Key Financials, 2012-2014 (Usd Mn)
Table 29 Lifeline Scientific Inc.: Key Financials, 2013-2014 (Usd Mn)
Table 30 Sigma-Aldrich Corporation : Key Financials, 2010-2014 (Usd Mn)
Table 31 Genzyme Corporation: Key Financials, 2012-2014 (Usd Mn)
Table 32 Teva Pharmaceuticals : Key Financials, By Business Segment,2011-2014 (Usd Mn) 82
List Of Figures
Figure 1 Global Biopreservation Market Segmentation & Coverage
Figure 2 Biopreservation Media Market: Integrated Ecosystem
Figure 3 Arriving At The Biopreservation Media Market Size
Figure 4 Top-Down Approach
Figure 5 Macro Indicator Approach
Figure 6 Global Biopreservation Media Market Snapshot
Figure 7 Global Biopreservation Media Market, By Geography, 2013-2019 (Usd Mn)
Figure 8 North America Biopreservation Media Market, By Application, 2013-2019 (Usd Mn)
Figure 9 Europe Biopreservation Market, By Application, 2013-2019 (Usd Mn)
Figure 10 Apac Biopreservation Media Market, By Application, 2013-2019 (Usd Mn)
Figure 11 Row Biopreservation Media Market, By Application, 2013-2019 (Usd Mn)
Figure 12 Global Biopreservation Media Market, By Type, 2013–2019 (Usd Mn)
Figure 13 Global Home-Brew Media Market, By Application, 2013–2019 (Usd Mn)
Figure 14 Global Pre-Formulated Media Market, By Application, 2013–2019 (Usd Mn)
Figure 15 Global Biopreservation Media Market, By Application, 2013-2019 (Usd Mn)
Figure 16 North America Biopreservation Media Market, By Application,2013-2019 (Usd Mn) 34
Figure 17 Europe Biopreservation Media Market, By Application, 2013-2019 (Usd Mn)
Figure 18 Apac Biopreservation Media Market, By Application, 2013-2019 (Usd Mn)
Figure 19 North America Biopreservation Media Market Overview, 2014 & 2019 (%)
Figure 20 North America Biopreservation Media Market, By Application,2013-2019 (Usd Mn) 40
Figure 21 North America Biopreservation Media Market Share, By Application,2014 & 2019 (%) 41
Figure 22 Europe Biopreservation Media Market Overview, 2014 & 2019 (%)
Figure 23 Europe Biopreservation Media Market, By Application, 2013-2019 (Usd Mn)
Figure 24 Europe Biopreservation Media Market Share, By Application,2014 & 2019 (%) 44
Figure 25 Apac Biopreservation Media Market Overview, 2014 & 2019 (%)
Figure 26 Apac Biopreservation Media Market, By Application, 2013-2019 (Usd Mn)
Figure 27 Apac Biopreservation Media Market Share, By Application, 2014 & 2019 (%)
Figure 28 Row Biopreservation Media Market Overview, 2014 & 2019 (%)
Figure 29 Row Biopreservation Media Market, By Application, 2013-2019 (Usd Mn)
Figure 30 Row Biopreservation Media Market Share, By Application, 2014 & 2019 (%)
Figure 31 Biopreservation Media Market: Company Share Analysis In Bio Banking 2014 (%)
Figure 32 Biopreservation Media Market: Company Share Analysis In Regenerative Medicine, 2014 (%)
Figure 33 Biopreservation Media Market: Company Share Analysis In Drug Discovery, 2014 (%)
Figure 34 Thermo Fisher Scientific Inc.: Revenue Mix, 2014 (%)
Figure 35 Vwr International Llc: Revenue Mix, 2014 (%)
Figure 36 Biolife Solutions: Geographical Revenue Mix, 2014 (%)
Figure 37 Mylan N.V. Geographical Revenue Mix, 2014 (%)
Figure 38 Lifeline Scientific Inc. : Revenue Mix, 2014 (%)
Figure 39 Sigma-Aldrich Corporation : Revenue Mix, 2014 (%)
Figure 40 Teva Pharmaceutical Industries Ltd.: Revenue Mix, 2014 (%)
Advancements in tissue engineering and regenerative medicine in biology and engineering provide remedies for autoimmune diseases, such as diabetes, degenerative diseases, and even aging. With the emergence of these new disciplines in the field of medicine, there is a crucial need for development of parallel technologies such as biopreservation. Biopreservation is important for transportation and storage of natural and engineered tissues to maintain the stability and integrity of bio samples. Tissue engineering involves processing of cells and tissues and manipulating them outside the body. It is hence mandatory to preserve these cells and tissues so that they do not lose their quality and integrity.
The global biopreservation media market was dominated by North America in 2014, followed by Europe, Asia-Pacific, and Rest of the World (RoW). North America will continue to lead the biopreservation media market in coming years, followed by Europe. Over the years, North America has witnessed significant growth in the biopreservation of cells, tissues, and organs owing to advancements in the medical research, clinical trials, and biopharmaceutical industries. Investments and support by the U.S. government is an impetus for further growth and development of the biopreservation market in the country.
The global biopreservation media market was valued at $247.7 million in 2014. The North American, European, and Asia-Pacific biopreservation media markets were valued at $117.4 million, $73.0 million, and $38.3 million respectively in 2014. North America and European markets are projected to register CAGR of 17.7% and 18.2% to reach $265.0 million and $168.6 million respectively by 2019.
The market has been segmented by application into regenerative medicines, drug discovery and biobanking. Out of these, the regenerative medicines segment accounts for the largest market share.
Growth in the Asia-Pacific market is likely to be propelled by gradually increasing awareness, investments by government and non-government organizations, and establishment of research centres. Some of the major players in the global biopreservation media market are Essential Pharmaceuticals LLC (U.S.), BioLife Solutions, Inc. (U.S.), Lifeline Scientific, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Lonza Group Ltd. (Switzerland), Mylan N.V. (U.S.), Genzyme Corporation (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Akron Biotech (U.S.), OriGen Biomedical (U.S.), and Wak-Chemie Medical GmbH (Germany).
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE | PUBLISHED | |
---|---|---|
Non-optimized, Isotonic Formulation Media Non-optimized, Isotonic Formulation Media and Optimized Pre-formulated Media adds up to total |
Upcoming | |
Optimized Pre-formulated Media Optimized Pre-formulated Media and Non-optimized, Isotonic Formulation Media adds up to total |
Upcoming | |
Home Brew Biopreservation Media Home Brew Biopreservation Media and Pre-formulated Biopreservation Media adds up to total |
Upcoming | |
Pre-formulated Biopreservation Media Pre-formulated Biopreservation Media and Home Brew Biopreservation Media adds up to total |
Upcoming | |
North America Biopreservation Media The North American biopreservation media market is estimated to grow at a CAGR of 17.6% from 2016 to 2021. The biopreservation media market in the U.S. is the largest in the world and is growing at a steady pace. Regenerative medicines, biobanking, and drug discovery are the major application areas for biopreservation media for preserving cells, tissues, and organs. Due to rapid advancements in these application areas, the demand for biopreservation media is likely to grow extensively in coming years. |
Upcoming | |
Asia Pacific Biopreservation Media The research report categorizes the Asia pacific biopreservation media market by product type, by application and by country. Based on product type, the market is categorized into home-brew media and pre-formulated media. Based on application, it is segmented into regenerative medicine, drug discovery and biobanking. Report covers major countries which includes Japan, China, India, Republic of Korea, and Australia. |
Upcoming | |
Europe Biopreservation Media The biopreservation media market is driven by factors such as development policies that regulate the use of human tissues for research and biobanking, and prospects of stem cell research development in European countries. Moreover, rise in the treatment of acute and chronic illnesses is leading a positive growth for this market. Investments in related research are also helping in expanding the market for biopreservation media. |
Upcoming |